Stay updated on Intepirdine in Dementia With Lewy Bodies: Clinical Trial
Sign up to get notified when there's something new on the Intepirdine in Dementia With Lewy Bodies: Clinical Trial page.

Latest updates to the Intepirdine in Dementia With Lewy Bodies: Clinical Trial page
- ChecktodayChange DetectedThe clinical-trial record for the HEADWAY-DLB study is now displayed, including its intepirdine treatment plan, eligibility criteria, participating locations, outcome measures, and study documents.SummaryDifference75%

- Check7 days agoChange DetectedThe page displays the ClinicalTrials.gov navigation and footer rather than the previous 403 error message. The study record content is not visible.SummaryDifference0.6%

- Check14 days agoChange DetectedA notice announces NIH’s website transition and says that “Super Intelligence” (SI) is being used in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer’s ClinicalTrials.gov revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study details with an access-denied message. This indicates restricted access to the record rather than a substantive content update.SummaryDifference18%

Stay in the know with updates to Intepirdine in Dementia With Lewy Bodies: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intepirdine in Dementia With Lewy Bodies: Clinical Trial page.